Roles for miRNAs in endocrine resistance in breast cancer

被引：74
|
作者：
Muluhngwi, Penn [1 ]
Klinge, Carolyn M. [1 ]
机构：
[1] Univ Louisville, Sch Med, Ctr Genet & Mol Med, Dept Biochem & Mol Genet, Louisville, KY 40292 USA
来源：
ENDOCRINE-RELATED CANCER | 2015年 / 22卷 / 05期
基金：
美国国家卫生研究院;
关键词：
antiestrogen; aromatase inhibitor; breast cancer; endocrine-resistance; estrogen receptor; miRNA; tamoxifen; ESTROGEN-RECEPTOR-ALPHA; NF-KAPPA-B; SIGNAL-TRANSDUCTION INHIBITORS; CONFERS TAMOXIFEN RESISTANCE; EXOSOME-MEDIATED TRANSFER; AROMATASE INHIBITORS; MESSENGER-RNAS; POSTMENOPAUSAL WOMEN; DOWN-REGULATION; UP-REGULATION;
D O I：
10.1530/ERC-15-0355
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Therapies targeting estrogen receptor alpha (ER alpha), including selective ER modulators such as tamoxifen, selective ER downregulators such as fulvestrant (ICI 182 780), and aromatase inhibitors such as letrozole, are successfully used in treating breast cancer patients whose initial tumor expresses ER alpha. Unfortunately, the effectiveness of endocrine therapies is limited by acquired resistance. The role of microRNAs (miRNAs) in the progression of endocrine-resistant breast cancer is of keen interest in developing biomarkers and therapies to counter metastatic disease. This review focuses on miRNAs implicated as disruptors of antiestrogen therapies, their bona fide gene targets and associated pathways promoting endocrine resistance.
引用
收藏
页码：R279 / R300
页数：22
相关论文
共 50 条
  • [1] Endocrine resistance in breast cancer: Current status and a perspective on the roles of miRNAs (Review)
    Zhou, Jichun
    Teng, Rongyue
    Wang, Qinchuan
    Xu, Chenpu
    Guo, Jufeng
    Yuan, Chao
    Shen, Jianguo
    Hu, Wenxian
    Wang, Linbo
    Xie, Shuduo
    ONCOLOGY LETTERS, 2013, 6 (02) : 295 - 305
  • [2] miRNAs modulating endocrine resistance in breast cancer
    Krell, Jonathan
    Frampton, Adam E.
    Cascorbi, Ingolf
    Werk, Anneke
    Stebbing, Justin
    PHARMACOGENOMICS, 2012, 13 (06) : 645 - 646
  • [3] Identification of miRNAs as biomarkers for acquired endocrine resistance in breast cancer
    Muluhngwi, Penn
    Klinge, Carolyn M.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2017, 456 (0C) : 76 - 86
  • [4] Emerging roles of exosomal miRNAs in breast cancer drug resistance
    Najminejad, Hamid
    Kalantar, Seyed Mehdi
    Abdollahpour-Alitappeh, Meghdad
    Karimi, Mohammad Hossein
    Seifalian, Alexander M.
    Gholipourmalekabadi, Mazaher
    Sheikhha, Mohammad Hasan
    IUBMB LIFE, 2019, 71 (11) : 1672 - 1684
  • [5] Identification of miRNAs and Their Associated Target Genes Involved in Endocrine Resistance in Breast Cancer.
    Healy, N. A.
    Creighton, C. J.
    Fu, X.
    Tsimelzon, A.
    Hilsenbeck, S. G.
    Miller, N.
    Kerin, M. J.
    Osborne, C. K.
    Schiff, R.
    CANCER RESEARCH, 2011, 71
  • [6] Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance
    Garcia-Becerra, Rocio
    Santos, Nancy
    Diaz, Lorenza
    Camacho, Javier
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (01): : 108 - 145
  • [7] Endocrine resistance in breast cancer
    Zheng, L. H.
    Zhao, Y. H.
    Feng, H. L.
    Liu, Y. J.
    CLIMACTERIC, 2014, 17 (05) : 522 - 528
  • [8] Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA
    Hayes, Erin L.
    Lewis-Wambi, Joan S.
    BREAST CANCER RESEARCH, 2015, 17
  • [9] Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA
    Erin L Hayes
    Joan S Lewis-Wambi
    Breast Cancer Research, 17
  • [10] The roles of oncogenic miRNAs and their therapeutic importance in breast cancer
    O'Bryan, Samia
    Dong, Shengli
    Mathis, J. Michael
    Alahari, Suresh K.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : 1 - 11
12345